Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02427932 · ClinicalTrials.gov registry record
Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 45
- Enrollment target
NCT02427932: Completed study, sponsored by Stanford University.
NCT02427932 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02427932 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
This study proposes to compare the metabolism of Ampicillin and Gentamicin by pregnant women to that of non-pregnant women; the placental transfer over time; and the subsequent metabolism of the transferred drug(s) in the neonate.
Interventions
- DRUG Gentamicin
- DRUG Ampicillin
- DRUG Ampicillin and Gentamicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02427932
The ClinicalTrials.gov registry entry for NCT02427932 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Gentamicin is the first listed.
NCT02427932 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02427932 about?
NCT02427932 is a clinical study titled "Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients". This study proposes to compare the metabolism of Ampicillin and Gentamicin by pregnant women to that of non-pregnant women; the placental transfer over time; and the subsequent metabolism of the transferred drug(s) in the neonate.
What is the current status of trial NCT02427932?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2015-05. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02427932?
The interventions under investigation include: Gentamicin (DRUG), Ampicillin (DRUG), Ampicillin and Gentamicin (DRUG).
Who is sponsoring clinical trial NCT02427932?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.